In-Person Workshops
Designed for the real challenges of entering the US market from a European perspective with US expertise
Half day, full day, and multi-day workshops that get straight to business
Intense, straightforward workshops on where European value propositions get adopted fastest, how to read the systems, and how to win both home and abroad
Not generic advice
Learn what works in the real world: incentive, procurement, and economic alignment across European and US models so participants leave equipped to navigate multiple markets.
Directed at commercialization
Everything else is tablestakes; commercialization is how businesses get made. We get into the things that make or break the P&L.
Action over theory
Participants leave with action plans, decision points, and the knowledge to determine what’s real, what’s noise, and what’s next.
Tailored workshops for new market expansion
No two workshops are exactly alike, but we focus on providing an intense curriculum designed to teach participants how to “read” the systems at play so they can make stronger decisions themselves. We tailor to specific therapeutic areas, modalities, stages, and regions to make sure the information is extremely relevant. Advanced workshops may have prerequisites and are designed to leave participants with real-world tools to put to practice.
Half-day, full-day, and multi-day programs
Active group work with real-world case studies
Specific, practical tools and resources
Current to ongoing shifts and changes
Workshop concentrations
Transatlantic Commericalization
Business model fit and the foundation for a reality-based market strategy aimed at preserving optionality and accelerating market uptake and expansion.
Access to investment
Risk and strategic thinking
Alternate forms of investment
CLEAR/IT framework methodology
Translating EU-native strengths into the US model spectrum
Business model and market strategy for transatlantic scale
Procurement, pricing, and basic US health economics
Fundraising from US investors in 2026
Creating optionality in uncertain times
Reimbursement and working with payers
Designing the right sales structure
Investment narrative and runway alignment
Risk management in testing new markets
Due diligence and data rooms
Hedging bets in features and pricing
Pricing and value engineering to win value-based deals
Early revenue, partnerships, and distribution plays
Risk from an investment perspective
Designing governance for both US and EU
FAQs
-
Yes, and much more systematically and in-depth than many do because many of the typical reimbursement pathways don’t reflect the value propositions that European startups propose. The result is that they pursue reimbursement that still doesn’t lead to adoption.
This is why it’s critical to work with those who understand multiple health models and true health economics.
-
No, although we do consider ourselves US experts. We also teach market access for the UK and Germany, and also teach courses on health economics and comparative health systems across the EU, ANZ, and US.
-
In-person will always be more engaging, particularly as we usually have the opportunity to train cluster leaders and BDMs while there. Depending on the length, we aim to incorporate small group work during the sessions, which is more difficult to do virtually.
That said, our virtual workshops make a low-friction way to support a larger range of entrepreneurs.
